Developing a functional precision medicine assay to predict pathological complete response in patients with triple-negative breast cancer: Interim results from the PEAR-TNBC Trial
Peter Hall, Matt Williams, Elenora Peerani, El li Tham, Francesco Iori, George de Fraine, Kerrie Loughrey, Andreas Kaffa, Thomas Richardson, Angeliki Velentza-Almpani, Demi Wiskerke, Farah Sangkola, Aston Crawley, Jay Kearney, Nourdine Bah, Marios Tasoulis, Cliona KIrwan, Susan Cleator, Steve Chan, Duleek Ranatunga
medRxiv 2024.10.25.24314885; doi: https://doi.org/10.1101/2024.10.25.24314885